title: A pilot test of a combined tobacco dependence treatment and lung cancer screening program.
abstract: Lung cancer screening with computed tomography has demonstrated a significant reduction in mortality. While these findings are important for the lung cancer research field, the most important risk factor for lung cancer, i.e. smoking, should not be ignored. We performed a pilot study to examine the feasibility of delivering a program that included both tobacco dependence treatment and lung cancer screening. The objectives of this study were to: (1) estimate the proportion of smokers who complied with a 12-week treatment protocol that included both tobacco dependence treatment and lung cancer screening, (2) obtain preliminary estimates of abstinence and quit attempts at 4 and 6 months, and (3) obtain preliminary estimates of the cognitive social health information processing (C-SHIP) constructs and how they change following the intervention. In this randomized pilot study, 18 volunteers completed a 12-week protocol: half received the tobacco dependence treatment program before a CT scan (BCT) and the other received the CT scan first, followed by the treatment program (ACT). The treatment protocol included both nurse-delivered telephone counseling and either nicotine replacement therapy or varenicline. Only one person did not complete all follow-up evaluations. At 4 months post enrollment, the carbon monoxide confirmed quit rates were 33.3% in the BCT arm and 22.2% in the ACT arm (27.8% overall), and all but one had made a 24-h attempt to quit. At 6 months the confirmed abstinence decreased to 22.1% in the BCT arm and 11.1% in the ACT arm (16.7% overall), and 72.2% of participants had made a 24-h quit attempt. These preliminary results suggest that it might be better to deliver treatment before the screening test. Future randomized trials with a larger sample size are needed to confirm these findings.
authors.affiliation: The Ohio State University College of Public Health, Columbus, OH 43210, USA. aferketich@cph.osu.edu
authors.forename: Amy K
authors.initials: AK
authors.lastname: Ferketich
authors.forename: Gregory A
authors.initials: GA
authors.lastname: Otterson
authors.forename: Mark
authors.initials: M
authors.lastname: King
authors.forename: Nathan
authors.initials: N
authors.lastname: Hall
authors.forename: Kristine K
authors.initials: KK
authors.lastname: Browning
authors.forename: Mary Ellen
authors.initials: ME
authors.lastname: Wewers
mesh_terms: D001552:Benzazepines / Q000627:therapeutic use; D055088:Early Detection of Cancer / Q000379:methods*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis*; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D011810:Quinoxalines / Q000627:therapeutic use; D012907:Smoking / Q000009:adverse effects; D016540:Smoking Cessation / Q000379:methods*; D061485:Tobacco Use Cessation Devices; D014029:Tobacco Use Disorder / Q000628:therapy*; D014057:Tomography, X-Ray Computed / Q000379:methods; D000068580:Varenicline
chemical_list: D001552:Benzazepines; D011810:Quinoxalines; D000068580:Varenicline
references.citation: Addict Behav. 2006 Jan;31(1):42-56
references.pmid: 15916861
references.citation: Radiology. 2005 Apr;235(1):259-65
references.pmid: 15695622
references.citation: J Health Psychol. 2010 Mar;15(2):205-14
references.pmid: 20207664
references.citation: Res Nurs Health. 2006 Aug;29(4):359-70
references.pmid: 16847914
references.citation: Addict Behav. 2002 Mar-Apr;27(2):293-307
references.pmid: 11817769
references.citation: N Engl J Med. 2011 Aug 4;365(5):395-409
references.pmid: 21714641
references.citation: J Pers Soc Psychol. 1985 May;48(5):1279-89
references.pmid: 3998990
references.citation: Ann Behav Med. 2003 Summer;25(3):214-22
references.pmid: 12763716
references.citation: Lung Cancer. 2007 Apr;56(1):125-34
references.pmid: 17196298
references.citation: Lung Cancer. 2003 Mar;39(3):315-25
references.pmid: 12609570
references.citation: Cancer. 2003 Dec 1;98(11):2495-501
references.pmid: 14635086
references.citation: Eur J Cardiovasc Prev Rehabil. 2007 Feb;14(1):51-8
references.pmid: 17301627
references.citation: Thorax. 2009 May;64(5):388-92
references.pmid: 19052048
references.citation: Lung Cancer. 2004 Apr;44(1):13-21
references.pmid: 15013579
references.citation: Behav Res Ther. 2003 Sep;41(9):1081-92
references.pmid: 12914809
references.citation: Addict Behav. 1990;15(3):271-83
references.pmid: 2378287
references.citation: Prev Med. 2001 Dec;33(6):613-21
references.pmid: 11716658
references.citation: Cancer Epidemiol Biomarkers Prev. 2009 Dec;18(12):3484-9
references.pmid: 19959699
references.citation: BMJ. 2010 Jan 21;340:b5569
references.pmid: 20093278
references.citation: Br J Addict. 1991 Sep;86(9):1119-27
references.pmid: 1932883
references.citation: Patient Educ Couns. 2010 Jan;78(1):57-64
references.pmid: 19660890
references.citation: Psychol Bull. 1996 Jan;119(1):70-94
references.pmid: 8559860
references.citation: Nicotine Tob Res. 2002 May;4(2):149-59
references.pmid: 12028847
references.citation: Cancer. 2005 May 15;103(10):2154-62
references.pmid: 15825210
references.citation: Lung Cancer. 2002 Sep;37(3):257-65
references.pmid: 12234693
references.citation: Eur Respir J. 2011 Jun;37(6):1466-73
references.pmid: 21148233
references.citation: Cancer Epidemiol Biomarkers Prev. 2009 Dec;18(12):3451-8
references.pmid: 19959695